Cystatin C As an Early Marker of Cardiorenal Syndrome Type 1 in Patients Admitted With Acute Heart Failure. Nep. Med. Coll. J. 2022, 24 (4), 316-320. https://doi.org/10.3126/nmcj.v24i4.50586.